An economic analysis of arthralgia/myalgia versus recurrence in women with hormone receptor-positive (HR plus ) breast cancer (BC) on aromatase inhibitors (AIs)

被引：0

作者：

Hadji, P. ^{[1
]}

机构：

[1] Univ Marburg, Dept Endocrinol, Marburg, Germany

来源：

EJC SUPPLEMENTS | 2009年 / 7卷 / 02期

关键词：

D O I：

10.1016/S1359-6349(09)70720-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：210 / 211

页数：2

共 50 条

[1] An economic analysis of arthralgia/myalgia (A/M) versus recurrence in women with hormone receptor-positive (HR plus ) breast cancer (BC) on aromatase inhibitors (AIs)
Hadji, P.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[2] Patient-reported outcomes, perceptions, and knowledge about recurrence in women with high-risk hormone receptor-positive (HR plus ) breast cancer (BC)
Rosenberg, Shoshana
Zheng, Yue
Santos, Katheryn
Riley, Elizabeth
Meadows, Hugh
Snow, Craig
Hughes, Melissa E.
Frank, Elizabeth
Lin, Nancy U.
Partridge, Ann
Winer, Eric
Parsons, Heather A.
[J]. CANCER RESEARCH, 2023, 83 (05)
[3] Impact of hormonal therapy (HT) on cognitive function in postmenopausal women (PMW) with hormone receptor-positive (HR plus ) breast cancer (BC)
Untch, M.
O'Regan, R.
[J]. EJC SUPPLEMENTS, 2009, 7 (02): : 301 - 301
[4] POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE BREAST CANCER: BALANCING BENEFIT AND TOXICITY FROM AROMATASE INHIBITORS
Ingle, J.
[J]. BREAST, 2013, 22 : S19 - S19
[5] Postmenopausal women with hormone receptor-positive breast cancer: Balancing benefit and toxicity from aromatase inhibitors
Ingle, James N.
[J]. BREAST, 2013, 22 : S180 - S183
[6] Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
Arnedos, M.
Drury, S.
Afentakis, M.
A'Hern, R.
Hills, M.
Salter, J.
Smith, I. E.
Reis-Filho, J. S.
Dowsett, M.
[J]. ANNALS OF ONCOLOGY, 2014, 25 (03) : 605 - 610
[7] The effect of using adjuvant aromatase inhibitors on cognitive functions in postmenopausal women with hormone receptor-positive breast cancer
Ilhan, Rukiye Guler
Ilhan, Yusuf
Goksu, Sema Sezgin
Tatli, Ali Murat
Coskun, Hasan Senol
[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S368 - S372
[8] Predicting nodal positivity in women with hormone receptor-positive (HR plus ), early stage breast cancer (ESBC).
Ray, Emily Miller
Strassle, Paula D.
Gaber, Charles E.
Muss, Hyman B.
Downs-Canner, Stephanie M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[9] The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer
Benson, JR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6807 - 6809
[10] Cyclin D1 as a biomarker of response to fulvestrant (F) in hormone receptor-positive (HR plus ) breast cancer (BC).
Cascetta, Krystal Pauline
Germain, Doris
Tiersten, Amy
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →